Aug
23
Mon
2021
General Surgery Meet & Greet for Prospective Applications
Aug 23 @ 5:00 pm – 6:00 pm
Join us Monday, August 23 at 5PM PST (8PM EST) to learn about the Department of Surgery at Stanford University and our General Surgery Residency Program. This one-hour program will offer attendees the opportunity to hear from current residents and Department leadership.
Register here!
Agenda:

  • Learn about our Department’s values, the facilities where our residents train and how our Professional Development curriculum allows our trainees to individualize their education.
  • Q&A with Department leaders including our Chair Dr. Mary Hawn, Vice Chair of Education Dr. Jim Korndorffer, and Vice Chair of Research Dr. Arden Morris
  • Move into breakout rooms for conversation with current residents.
Sep
28
Tue
2021
Grand Rounds: Dr. Martha Zeiger
Sep 28 @ 7:00 am – 8:00 am
Nov
23
Tue
2021
General Surgery Alumni Lecture: Dr. George Yang
Nov 23 @ 7:00 am – 8:00 am
Jan
25
Tue
2022
Grand Rounds: Dr. Joe Forrester
Jan 25 @ 7:00 am – 8:00 am
Feb
1
Tue
2022
Academic Surgical Congress
Feb 1 – Feb 3 all-day
Feb
22
Tue
2022
Grand Rounds: Dr. Ali Tavakkoli
Feb 22 @ 7:00 am – 8:00 am
Sep
30
Fri
2022
24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.